Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma-Reference-Cited by-同舟云学术

Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma

Published:2023-10 Issue: Volume:28 Page:376-385
ISSN:2452-199X
Container-title:Bioactive Materials
language:en
Short-container-title:Bioactive Materials

Author:

Chen Dafu^ORCID,Lei Chengyue,Liu Weifeng,Shao Meiyu,Sun Meizhou,Guo Jianxun,Cao Jingjing,Nie Jing-Jun,Luo Peng,Luo Yuwen,Yu Bingran^ORCID,Wang Renxian^ORCID,Duan Shun^ORCID,Xu Fu-Jian^ORCID

Publisher

Elsevier BV

Subject

Biomedical Engineering,Biomaterials,Biotechnology

Reference43 articles.

1. Cancer incidence and mortality in China, 2016;Zheng;J. Natl. Cancer Center,2022

2. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J. Clin. Oncol.,2002

3. Annual report to the nation on the status of cancer, Part 1: national cancer statistics;Islami;J. Natl. Cancer Inst.,2021

4. Osteosarcoma: current treatment and a collaborative pathway to success;Isakoff;J. Clin. Oncol.,2015

5. Osteosarcoma treatment – where do we stand? A state-of-the-art review;Luetke;Cancer Treat Rev.,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma;International Journal of Nanomedicine;2024-08

2. The Role of Long Non-Coding RNF144A-AS1 in Cancer Progression;Cell Biochemistry and Biophysics;2024-07-16

3. Recent progress in diagnostic imaging and therapeutics of osteosarcoma based on multifunctional nanoparticles;Science China Chemistry;2024-07-11

4. Recent developments of polymeric delivery systems in gene therapeutics;Polymer Chemistry;2024

5. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma;Open Life Sciences;2024-01-01